Travere Therapeutics (TVTX)
(Real Time Quote from BATS)
$6.55 USD
+0.21 (3.31%)
Updated May 14, 2024 11:12 AM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.84 |
EPS Last Quarter | -1.76 |
Last EPS Surprise | -79.59% |
ABR | 1.50 |
Earnings ESP
|
-2.44% |
---|---|
Current Year | -3.66 |
Next Year | -1.72 |
EPS (TTM) | -5.22 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 51.55M | 56.12M | 209.62M | 317.36M |
# of Estimates | 8 | 8 | 8 | 8 |
High Estimate | 70.01M | 74.80M | 231.20M | 512.67M |
Low Estimate | 47.00M | 46.80M | 184.37M | 218.42M |
Year ago Sales | 59.70M | 37.10M | 198.84M | 209.62M |
Year over Year Growth Est. | -13.65% | 51.26% | 5.42% | 51.40% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.84 | -0.71 | -3.66 | -1.72 |
# of Estimates | 9 | 8 | 8 | 9 |
Most Recent Consensus | -0.83 | -0.66 | -3.83 | -1.44 |
High Estimate | -0.44 | -0.56 | -2.44 | 0.25 |
Low Estimate | -1.06 | -0.97 | -4.62 | -2.46 |
Year ago EPS | -1.13 | -1.17 | -5.07 | -3.66 |
Year over Year Growth Est. | 25.66% | 39.32% | 27.81% | 52.95% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 2 | 0 | 4 |
Up Last 30 Days | 3 | 4 | 0 | 6 |
Up Last 60 Days | 3 | 4 | 0 | 6 |
Down Last 7 Days | 2 | 1 | 4 | 0 |
Down Last 30 Days | 4 | 2 | 7 | 1 |
Down Last 60 Days | 4 | 2 | 7 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.84 | -0.71 | -3.66 | -1.72 |
7 Days Ago | -0.82 | -0.71 | -3.24 | -1.92 |
30 Days Ago | -0.81 | -0.71 | -2.98 | -1.85 |
60 Days Ago | -0.81 | -0.71 | -2.98 | -1.85 |
90 Days Ago | -0.79 | -0.71 | -3.08 | -1.53 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.87 | -0.75 | -3.83 | -1.63 |
Zacks Consensus Estimate | -0.84 | -0.71 | -3.66 | -1.72 |
Earnings ESP | -2.44% | -5.96% | -4.61% | 5.56% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.76 | -1.16 | -1.17 | -1.13 | NA |
Estimate | -0.98 | -1.27 | -1.09 | -1.16 | NA |
Difference | -0.78 | 0.11 | -0.08 | 0.03 | -0.18 |
Surprise | -79.59% | 8.66% | -7.34% | 2.59% | -18.92% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more